We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+6.52%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$360M
AUM Growth
+$23.2M
Cap. Flow
+$4.42M
Cap. Flow %
1.23%
Top 10 Hldgs %
35.36%
Holding
154
New
8
Increased
52
Reduced
50
Closed
5

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$2.21M
2
MKTX icon
MarketAxess Holdings
MKTX
+$1.8M
3
TDC icon
Teradata
TDC
+$1.03M
4
EMC
EMC CORPORATION
EMC
+$889K
5
CLH icon
Clean Harbors
CLH
+$831K

Sector Composition

Rank Sector Weight
1 Healthcare 29.62%
2 Technology 25.3%
3 Industrials 15.98%
4 Consumer Staples 10.73%
5 Financials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$339B
$19.7M 5.48%
261,084
+4,464
+2% +$355K
CVS icon
2
CVS Health
CVS
$122B
$15.4M 4.26%
270,546
+3,855
+1% +$230K
ADP icon
3
Automatic Data Processing
ADP
$108B
$13.1M 3.63%
205,932
+34
+0% +$2.16K
JCI icon
4
Johnson Controls International
JCI
$92.2B
$12.6M 3.5%
290,064
+2,048
+0.7% +$86.8K
JNJ icon
5
Johnson & Johnson
JNJ
$625B
$12.4M 3.45%
143,276
+15
+0% +$1.35K
NVS icon
6
Novartis
NVS
$297B
$12.4M 3.44%
180,476
+1,919
+1% +$127K
EMR icon
7
Emerson Electric
EMR
$88.3B
$12.1M 3.35%
186,839
+3,500
+2% +$214K
GSK icon
8
GSK
GSK
$106B
$11.3M 3.12%
179,478
+9,250
+5% +$595K
EMC
9
DELISTED
EMC CORPORATION
EMC
$9.59M 2.66%
374,997
+34,240
+10% +$889K
TEVA icon
10
Teva Pharmaceuticals
TEVA
$41.2B
$8.88M 2.46%
235,066
-3,285
-1% -$128K
ROK icon
11
Rockwell Automation
ROK
$49B
$8.08M 2.24%
75,539
+7,574
+11% +$740K
AAPL icon
12
Apple
AAPL
$4.57T
$7.7M 2.14%
452,284
+12,236
+3% +$203K
NXPI icon
13
NXP Semiconductors
NXPI
$60.4B
$7.69M 2.13%
206,630
-100
-0% -$3.54K
CSCO icon
14
Cisco
CSCO
$479B
$7.42M 2.06%
316,798
+10,250
+3% +$254K
ILMN icon
15
Illumina
ILMN
$28.4B
$6.95M 1.93%
88,326
+196
+0.2% +$15K
LH icon
16
Labcorp
LH
$25.9B
$6.88M 1.91%
80,750
+599
+0.7% +$50.4K
ATR icon
17
AptarGroup
ATR
$8.61B
$6.69M 1.86%
111,297
+2,800
+3% +$166K
SSYS icon
18
Stratasys
SSYS
$774M
$6.66M 1.85%
65,732
-6,095
-8% -$590K
CNI icon
19
Canadian National Railway
CNI
$76.6B
$6.43M 1.78%
126,818
+1,200
+1% +$59.2K
PRGO icon
20
Perrigo
PRGO
$1.78B
$6.15M 1.71%
49,880
+175
+0.4% +$21.8K
MA icon
21
Mastercard
MA
$493B
$6.01M 1.67%
89,300
-250
-0.3% -$15.7K
INTC icon
22
Intel
INTC
$513B
$5.69M 1.58%
248,246
-2,947
-1% -$67.9K
GLW icon
23
Corning
GLW
$143B
$5.62M 1.56%
385,425
+16,025
+4% +$237K
WOLF icon
24
Wolfspeed
WOLF
$1.71B
$5.39M 1.5%
89,574
-252
-0.3% -$16K
TDC icon
25
Teradata
TDC
$2.55B
$5.35M 1.49%
96,548
+17,555
+22% +$1.03M

Similar funds

Reynders McVeigh Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Reynders McVeigh Capital Management held 154 positions worth $360M, up 6.9% from $337M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management's Q3 2013 filing shows 8 new, 52 increased, 50 reduced and 5 closed positions. Its largest new stake was Xylem: 82,815 shares worth $2.31M. The largest sale was Monsanto Co, an estimated $3.56M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q3 2013 buy was Xylem: 82,815 shares worth $2.31M.
  • Reynders McVeigh Capital Management added most to MarketAxess Holdings in Q3 2013, an estimated $1.8M increase.
  • Reynders McVeigh Capital Management's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $3.56M.
  • Reynders McVeigh Capital Management fully exited Calgon Carbon Corp in Q3 2013, selling an estimated $246K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $360M portfolio in Q3 2013.
  • Reynders McVeigh Capital Management opened 8 new positions and closed 5 in Q3 2013.
  • Reynders McVeigh Capital Management's portfolio value rose 6.9% quarter-over-quarter to $360M.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2013, filed 8 Nov 2013.